Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
40.79
+0.70 (1.75%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Xenon Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for XENE stock have an average target of 58.75, with a low estimate of 49 and a high estimate of 65. The average target predicts an increase of 44.03% from the current stock price of 40.79.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for XENE stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Buy | 6 | 5 | 5 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +34.84% | Sep 3, 2024 |
| Needham | Needham | Strong Buy Maintains $62 → $60 | Strong Buy | Maintains | $62 → $60 | +47.09% | Aug 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +59.35% | Aug 9, 2024 |
| Wedbush | Wedbush | Buy Maintains $50 → $49 | Buy | Maintains | $50 → $49 | +20.13% | Aug 9, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +34.84% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
340.00K
Revenue Next Year
5.78M
from 340.00K
Increased by 1,600.02%
EPS This Year
-3.18
from -2.73
EPS Next Year
-3.66
from -3.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 78.8M | 113.5M | ||
| Avg | 339,997 | 5.8M | 52.4M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 23,062.0% | 1,864.2% | ||
| Avg | - | 1,600.0% | 805.9% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.00 | -2.48 | -2.90 | ||
| Avg | -3.18 | -3.66 | -3.90 | ||
| Low | -3.37 | -4.18 | -4.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.